Open AccessThe Breast Cancer Susceptibility Gene BRCA1 Is Required for Subnuclear Assembly of Rad51 and Survival following Treatment with the DNA Cross-linking Agent Cisplatin
Author(s) -
Anamitra Bhattacharyya,
Uy Ear,
Beverly H. Koller,
Ralph R. Weichselbaum,
Douglas K. Bishop
Publication year - 2000
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/7d45-4d53
Subject(s) - rad51 , cisplatin , breast cancer , dna , cancer research , oncology , medicine , dna repair , cancer , biology , genetics , chemotherapy